Zucara Therapeutics Inc., a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that ...

The context: Last week, shares in US vaccine manufacturers Pfizer and Moderna, as well as in European counterparts GSK and ...

New research published by the European Federation of Industries and Associations (EFPIA) provides in-depth analysis of the ...

Jasper Therapeutics, Inc.'s Briquilimab shows promise in treating chronic urticaria and asthma, with potential market ...

Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for ...

Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company's purchase of Sanofi's rare immune ...

Nifty moved in a tight range of 82 points, and ended slightly below the psychologically crucial level of 15,700. NEW DELHI: ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

The White House appointment of the anti-vax conspiracy theorist is devastating ASX healthcare and biotech shares as he ...

Sanofi, a leading global healthcare company, has received the “Corporate Social Impact Award 2024 – Gold level” for the fifth ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...